Conexeu Sciences Inc. (CNXU) vs Citius Oncology, Inc. (CTOR)

A side-by-side comparison of Conexeu Sciences Inc. and Citius Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CNXU

Conexeu Sciences Inc.

$84M

$3.15HealthcareDelayed quote: Oct 6, 2026, 10:14 AM EDT

CTOR

Citius Oncology, Inc.

$83M

$0.89HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT

Total return — CNXU vs CTOR

growth of $100 · dividends reinvested · last 1y

CNXU -76.1% (-76.1%/yr)CTOR +5.4% (+5.4%/yr)CTOR compounded faster over this window

CNXU CTOR

Metrics side by side

Total return (annualized)

Metric	CNXU	CTOR
Total return (1Y)	N/A	-53.61%

CNXU is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CNXU analysis Full CTOR analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.